Lee Kalowski, Chief Financial Officer at Tokai Pharmaceuticals Inc (TKAI), sold 2,258 shares at $11.45 ($26K) on 2015-04-02, disclosed to the SEC on 2015-04-06.
Scheduled sale ($26k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| QTTB | SELL | 2025-12-04 | $31K | — | Filing → |
| QTTB | SELL | 2025-08-28 | $8K | — | Filing → |
| BCYC | SELL | 2023-04-05 | $8K | — | Filing → |